These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 28183988)

  • 1. Molecular Imaging of Vulnerable Coronary Plaque: A Pathophysiologic Perspective.
    Krishnan S; Otaki Y; Doris M; Slipczuk L; Arnson Y; Rubeaux M; Dey D; Slomka P; Berman DS; Tamarappoo B
    J Nucl Med; 2017 Mar; 58(3):359-364. PubMed ID: 28183988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vulnerable plaque imaging using
    Kwiecinski J; Slomka PJ; Dweck MR; Newby DE; Berman DS
    Br J Radiol; 2020 Sep; 93(1113):20190797. PubMed ID: 31804143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted PET/CT imaging of vulnerable atherosclerotic plaques: microcalcification with sodium fluoride and inflammation with fluorodeoxyglucose.
    Chen W; Dilsizian V
    Curr Cardiol Rep; 2013 Jun; 15(6):364. PubMed ID: 23605466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atherosclerotic plaque metabolism in high cardiovascular risk subjects - A subclinical atherosclerosis imaging study with
    Oliveira-Santos M; Castelo-Branco M; Silva R; Gomes A; Chichorro N; Abrunhosa A; Donato P; Pedroso de Lima J; Pego M; Gonçalves L; Ferreira MJ
    Atherosclerosis; 2017 May; 260():41-46. PubMed ID: 28349887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging of inflamed and vulnerable plaque in coronary arteries with 18F-FDG PET/CT in patients with suppression of myocardial uptake using a low-carbohydrate, high-fat preparation.
    Wykrzykowska J; Lehman S; Williams G; Parker JA; Palmer MR; Varkey S; Kolodny G; Laham R
    J Nucl Med; 2009 Apr; 50(4):563-8. PubMed ID: 19289431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular imaging of atherosclerotic lesions by positron emission tomography - can it meet the expectations?
    Brammen L; Steiner S; Berent R; Sinzinger H
    Vasa; 2016; 45(2):125-32. PubMed ID: 27058798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging Molecular Targets for Imaging of Atherosclerotic Plaque using Positron Emission Tomography.
    Werner RA; Bengel FM; Derlin T
    Curr Radiopharm; 2021; 14(3):173-183. PubMed ID: 32368992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Target identification for the diagnosis and intervention of vulnerable atherosclerotic plaques beyond
    Bucerius J; Dijkgraaf I; Mottaghy FM; Schurgers LJ
    Eur J Nucl Med Mol Imaging; 2019 Jan; 46(1):251-265. PubMed ID: 30302506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular imaging of coronary inflammation.
    Pelletier-Galarneau M; Ruddy TD
    Trends Cardiovasc Med; 2019 May; 29(4):191-197. PubMed ID: 30195945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In search of the vulnerable patient or the vulnerable plaque:
    Bellinge JW; Francis RJ; Majeed K; Watts GF; Schultz CJ
    J Nucl Cardiol; 2018 Oct; 25(5):1774-1783. PubMed ID: 29992525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complementary value of cardiac FDG PET and CT for the characterization of atherosclerotic disease.
    Stolzmann P; Subramanian S; Abdelbaky A; Maurovich-Horvat P; Scheffel H; Tawakol A; Hoffmann U
    Radiographics; 2011; 31(5):1255-69. PubMed ID: 21918043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Science to Practice: Does FDG Differentiate Morphologically Unstable from Stable Atherosclerotic Plaque?
    Dilsizian V; Jadvar H
    Radiology; 2017 Apr; 283(1):1-3. PubMed ID: 28318446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of
    Kwiecinski J
    J Nucl Cardiol; 2024 May; 35():101845. PubMed ID: 38479575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging the Cytokine Receptor CXCR4 in Atherosclerotic Plaques with the Radiotracer
    Hyafil F; Pelisek J; Laitinen I; Schottelius M; Mohring M; Döring Y; van der Vorst EP; Kallmayer M; Steiger K; Poschenrieder A; Notni J; Fischer J; Baumgartner C; Rischpler C; Nekolla SG; Weber C; Eckstein HH; Wester HJ; Schwaiger M
    J Nucl Med; 2017 Mar; 58(3):499-506. PubMed ID: 27789718
    [No Abstract]   [Full Text] [Related]  

  • 15. Imaging Inflammation in Patients and Animals: Focus on PET Imaging the Vulnerable Plaque.
    Bartlett B; Ludewick HP; Lee S; Verma S; Francis RJ; Dwivedi G
    Cells; 2021 Sep; 10(10):. PubMed ID: 34685553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Clinical Role of PET in Atherosclerosis and Vulnerable Plaques?
    Lairez O; Hyafil F
    Semin Nucl Med; 2020 Jul; 50(4):311-318. PubMed ID: 32540028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Will 18F-sodium fluoride PET-CT imaging be the magic bullet for identifying vulnerable coronary atherosclerotic plaques?
    Joshi NV; Vesey A; Newby DE; Dweck MR
    Curr Cardiol Rep; 2014 Sep; 16(9):521. PubMed ID: 25103772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [¹⁸F-NaF PET-CT: a new method for imaging of ruptured and rupture-endangered atherosclerotic plaques].
    Avanesov M; Karul M; Derlin T
    Radiologe; 2014 Sep; 54(9):856-8. PubMed ID: 25106465
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of 68Ga-Glutamate Carboxypeptidase II Ligand Positron Emission Tomography for Clinical Molecular Imaging of Atherosclerotic Plaque Neovascularization.
    Derlin T; Thiele J; Weiberg D; Thackeray JT; Püschel K; Wester HJ; Aguirre Dávila L; Larena-Avellaneda A; Daum G; Bengel FM; Schumacher U
    Arterioscler Thromb Vasc Biol; 2016 Nov; 36(11):2213-2219. PubMed ID: 27609368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validity of dual MRI and F-FDG PET imaging in predicting vulnerable and inflamed carotid plaque.
    Saito H; Kuroda S; Hirata K; Magota K; Shiga T; Tamaki N; Yoshida D; Terae S; Nakayama N; Houkin K
    Cerebrovasc Dis; 2013; 35(4):370-7. PubMed ID: 23635390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.